AzTrials
AzTrials

Spinal Cord InjuriesNCT05811884

Patient-centered Assessment of the Effects of Powered Exoskeleton Use in People With Spinal Cord Injury

A study testing Rehabilitation in people with Spinal Cord Injuries, run by Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro at 1 site in Italy.

Suspended

Paused. Enrolment is on hold for now and may resume.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to assess the efficacy of the use of powered exoskeleton for ambulation on the quality of life in subjects with spinal cord injury. The main questions it aims to answer are: 1. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Spinal Cord Injuries
What is being tested?
Rehabilitation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteItaly
Study dates
Jan 2030to Feb 2033
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Assisted by Inail;
  • Age between 18 and 65 years;
  • Body weight lower than 113 Kg;
  • Level of spinal lesion T4 and higher;
  • Integrity of upper limbs (strength and range of motion assessed by a clinical operator);
  • Abbreviated Injury Scale (AIS) score A or B;
  • Number of months after lesion higher than 6;
  • Anthropometry in conformity with the declarations of exoskeleton's manufacturers.

Who cannot join

  • Use of the powered exoskeleton in the last 6 months (in this case a wash-out phase is required);
  • Use of colostomy bag;
  • The subject is pregnant/ nursing;
  • Presence of cognitive impairments;
  • Presence of severe neurologic lesions in addition to SCI (sclerosis, cerebral palsy or trauma,…);
  • Severe comorbidities;
Show all 15Show fewer
  • Uncontrolled hypertension or orthostatic hypotension;
  • Uncontrolled autonomic dysreflexia;
  • Problems at the skeletal system: T-score of femoral neck lower than -3 (DEXA examination is required), bone mineral density of proximal tibia or distal femur lower than 0.6 g/cm2, presence of non-recovered fractures, ectopic ossification, unstable spine;
  • Kinesiologic impairments of the lower limbs: Ashworth spasticity of hamstrings, quadriceps, gastrocnemius muscles (right/ left) lower than 4, uncontrolled clonic spasm, pathologic contractures: non conformity of the range of motion of ankle/ knee/ hip with the requisites for use of powered exoskeletons for ambulation, presence of pressure lesions, dysmetria: femurs higher than 1.5 cm/ tibias higher than 2 cm;
  • Kinesiologic impairments of the upper limbs: limitations at the joints, weakness of shoulder/ elbow/ hand (manual evaluation by a clinician), no autonomy in transfers;
  • Weak control of the trunk;
  • Inability to stand for at least 30 minutes;
  • Presence of joint prostheses in upper and lower limbs;
  • Use of drugs that may affect cognition and coordination while using the exoskeleton.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Centro Protesi Inail

    Budrio, Bologna, 40054

Other trials in Italy

About this study

The goal of this clinical trial is to assess the efficacy of the use of powered exoskeleton for ambulation on the quality of life in subjects with spinal cord injury. The main questions it aims to answer are:

  1. How much does the use of powered exoskeleton improve the quality of life in subjects with spinal cord injury after a 24 months treatment period in a house context (treatment 1) or in a clinical setting (treatment 2)?
  2. How much do the two treatments differ in terms of cost-utility ratio?
Read more

Participants will be included in a multi-step process consisting of:

  1. Recruitment, based on eligibility criteria;
  2. Observation of the "stability" over time (2 months) of specific clinical parameters;
  3. Training in the use of the powered exoskeleton (1 month);
  4. Random selection of the rehabilitation treatment (house rehabilitation or central rehabilitation); concerning the house rehabilitation, the subject will be provided the device for home use; concerning the central rehabilitation, the subject will be asked to use intensively the device 1-week every three months in a clinical facility.
  5. Follow-up: every six months each subject will be asked to attend a single-day activities session consisting of walking activities with the exoskeleton, compilation of questionnaires, sub-maximal effort test with arm-ergometer, and physical examinations made by a physiatrist.
Being tested
Rehabilitation
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RehabilitationDevice

    The subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible.

    The subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months.

    Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements.

Study groups in NCT05811884
Study groupRoleWhat they receive
House rehabilitationExperimentalThe subjects will be provided of the powered exoskeleton for home use. No specific indications will be provided, but using the technology as much as possible. Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements.
Receives: Device: Rehabilitation
Central rehabilitationExperimentalThe subjects will be asked to attend to periodic rehabilitation sessions by the clinical facility. The rehabilitation session will consist in an intense 1-week activities session every three months. Every six months, the subjects will be asked to attend a single-day session by the clinical facility (follow-up session) consisting on the assessement of a series of qualitative and quantitative measurements.
Receives: Device: Rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in quality of life (QoL)

    Short Form-36 questionnaire (SF-36): Generic health status measure. It applies to all health conditions and contains 36 items, divided in 8 domains. The higher the score, the higher the QoL.

    Measured: This outcome will be assessed at the baseline and immediately after the intervention

Secondary outcomes (15)
  1. Incremental cost utility ratio (ICUR) associated to the treatment

    Incremental cost utility ratio (ICUR) associated to the treatment: it provides healthcare decision- makers and providers with a straightforward information, that is, how much a "unit of utility improvement" would cost them and/or the society. Assuming a timeframe of analysis and two alternative technologies or treatments A and B, ICUR is the ratio between the difference in costs and the difference in utility of A and B

    Measured: This outcome will be assessed immediately after the intervention

  2. Incidence of Treatment-Emergent Adverse Events assessed by self-report and extracted from the medical records

    Incidence of major adverse events related to the exoskeleton use: falls, bone fractures, skin lesions, pressure lesions, cardiovascular events

    Measured: This outcome will be assessed immediately after the intervention

  3. Active use assessed by the number of strides and steps performed with the exoskeleton.

    Strides and steps performed with the exoskeleton are counted automatically by the exoskeleton system. This parameters can be monitored by connecting to the exoskeleton system via a proprietary software.

    Measured: This outcome will be assessed immediately after the intervention.

  4. Change in usability assessed by the System Usability Scale (SUS) questionnaire

    The SUS evaluates the usability of the assistive technology. It consists in 10 items with five response options for respondents, from Strongly agree to Strongly disagree. The participant's scores for each question are converted to a new number, added together and then multiplied by 2.5 to convert the original scores of 0-40 to 0-100. The higher the score, the higher the usability.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  5. Change in satisfaction assessed by the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST) questionnaire

    The QUEST evaluates a person's satisfaction with the assistive technology. It yields three scores: (i) Device, (ii) Services, and (iii) a total QUEST score. (i) consists of 10 items with five response options for respondents, from Strongly agree to Strongly disagree; the score is calculated by averaging the valid item responses; score range: 1-5. (ii) consists of 4 items with five response options for respondents, from Strongly agree to Strongly disagreeare; the score is calculated by averaging the valid item responses; score range: 1-5. (iii) is calculated by averaging the score of (i) and (ii). The QUEST presents a final section where the participants must indicate the three most important features of the technology.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  6. Change in mental status assessed by the Patient Health Questionnaire-9 (PHQ-9) questionnaire

    The PHQ-9 aims at identifying probable major depressive disorder among adult primary care patients. It consists in 9 items with four response options for respondents, from Never to Almost always. The final score is calculated by summing the valid item responses. Score range: 0 -27. The higher the score, the higher the level of depression.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  7. Change in mental status assessed by the General Anxiety Disorder Scale (GAD-7) questionnaire

    The GAD-7 assesses participant's anxiety. It consists of 7 items with four response options for respondents, from Never to Almost always. The final score is calculated by summing the valid item responses. Score range: 0 -21. The higher the score, the higher the level of anxiety.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  8. Change in fitness level assessed by the Metabolic Equivalents of Tasks (METs) associated to the consumption of oxygen (VO2) during a sub-maximal arm crank ergometer test

    The VO2 consumption is measured with a metabolic system throughout an exercise protocol with an arm-ergometer. According to previous study protocols, the VO2 consumption in the last 30 seconds of the arm-ergometer test are used to estimate the peak of VO2 consumption. After, this value is converted in METs.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  9. Change in muscular spasticity assessed by the Modified Ashworth Scale (MAS)

    The MAS assesses the resistance to passive range of motion about a single joint with a 6-point rating scale. It's performed by extending the patients limb first from a position of maximal possible flexion to maximal possible extension ( the point at which the first soft resistance is met). Afterwards, the modified Ashworth scale is assessed while moving from extension to flexion. The higher the score, the higher the muscular spasticity. The scores can assume the following values: 0 - No increase in tone;1 - slight increase in tone giving a catch when slight increase in muscle tone, manifested by the limb was moved in flexion or extension; 1+ - slight increase in muscle tone, manifested by a catch followed by minimal resistance throughout the range of motion; 2 -more marked increase in tone but more marked increased in muscle tone through most limb easily flexed; 3 - considerable increase in tone, passive movement difficult; 4 - limb rigid in flexion or extension.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  10. Change in integrity of the rotator cuff muscles assessed by Jobe's test and Speed's test

    The Jobe's test aids in diagnosing rotator cuff tears or subacromial impingement. The examiner passively elevates the patient's shoulder to 90 degrees of abduction with internal rotation. The examiner then applies a downward pressure against the arm. A positive test is the provocation of pain or abnormal weakness.

    The Speed's test is used to test for superior labral tears or bicipital tendonitis. To perform the Speed's Test, the examiner places the patient's arm in shoulder flexion, external rotation, full elbow extension, and forearm supination; manual resistance is then applied by the examiner in a downward direction. The test is considered to be positive if pain in the bicipital tendon or bicipital groove is reproduced In both test, the exerted force will be also measured using a dynamometer.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  11. Change in self-care and independence assessed by the Spinal Cord Independence Measure (SCIM) questionnaire

    The SCIM assesses of the ability of SCI patients to perform basic activities of daily living. It assesses three subscales: (i) self-care, (ii) respiration and sphincter management, and (iii) mobility. (i) consists in 6 items with four or five response options for respondents. Score range: 0-20. (ii) consists in 4 items with three to six response options for respondents. Score range: 0-40. (iii) consists in 8 items with three to nine response options for respondents. Score range: 0-40. Each subscale score is evaluated separately by summing the valid item responses. The higher the score, the higher the level of independence.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  12. Change in pain assessed by Visual Analogue Scale (VAS)

    The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression. It consists in a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured (pain in this case) orientated from the left (worst) to the right (best).

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  13. Change in sphincter's functionality assessed by a 5-Likert scale

    The 5-Likert scale consists of a single item which investigates the patients self-perceived sphincter's functionality, ranging from 1 (worst case) to 5 (best case)

    Measured: This outcome will be assessed at the beginning of the trial and at each follow-up (every 6 months) until trial completion

  14. Change in velocity during ambulation assessed by the 6 Minutes Walking Test (6 MWT)

    The 6 MWT is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

  15. Change in velocity during ambulation assessed by the 10 Meters Walking Test (10 MWT)

    The 10 MWT is a performance measure used to assess walking speed in meters per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.

    Measured: This outcome will be assessed at the baseline and at the months 6, 12, 18, 24

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2023
  2. Study startJan 2030 (estimated)
  3. Primary completionJan 2033 (estimated)
  4. Study completionFeb 2033 (estimated)

Why it stopped: Financial issues

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
18 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05811884
Sponsor's protocol ID
SSC DCAPR Prospettico
Status last verified
Apr 2025
First submitted
16 Mar 2023
Last updated
27 Mar 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Pseudonymized data could be shared upon request only

Questions about this trial

What is this clinical trial studying?

A study testing Rehabilitation in people with Spinal Cord Injuries, run by Istituto Nazionale Assicurazione contro gli Infortuni sul Lavoro at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: paused, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in quality of life (QoL) (time frame: This outcome will be assessed at the baseline and immediately after the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in